Carnegie Investment Counsel’s GE HealthCare GEHC Stock Holding History

Carnegie Investment Counsel’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$482K	Sell	7,527 -18,735	-71%	-$1.23M	0.01%	398
2026 Q1	$1.87M	Buy	26,262 +764	+3%	+$60.2K	0.04%	263
2025 Q4	$2.09M	Buy	25,498 +4,604	+22%	+$359K	0.04%	258
2025 Q3	$1.57M	Sell	20,894 -5,268	-20%	-$393K	0.03%	272
2025 Q2	$1.94M	Buy	26,162 +15,925	+156%	+$1.11M	0.04%	243
2025 Q1	$624K	Sell	10,237 -257	-2%	-$22.1K	0.01%	342
2024 Q4	$820K	Buy	10,494 +26	+0.2%	+$2.21K	0.02%	283
2024 Q3	$982K	Sell	10,468 -30	-0.3%	-$2.52K	0.03%	274
2024 Q2	$818K	Sell	10,498 -2,634	-20%	-$215K	0.03%	286
2024 Q1	$1.19M	Sell	13,132 -1,611	-11%	-$134K	0.04%	273
2023 Q4	$1.14M	Sell	14,743 -1,389	-9%	-$97.3K	0.04%	264
2023 Q3	$1.1M	Sell	16,132 -35,160	-69%	-$2.56M	0.04%	265
2023 Q2	$4.17M	Buy	51,292 +23,147	+82%	+$1.85M	0.15%	146
2023 Q1	$2.31M	Buy	+28,145	New	+$2.01M	0.09%	191

Other funds holding GEHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Carnegie Investment Counsel's GEHC Position: Q2 2026 in Review

Carnegie Investment Counsel reduced its GE HealthCare (GEHC) stake by 71% in Q2 2026, selling an estimated $1.23M and leaving 7,527 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #398.

Carnegie Investment Counsel first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.17M in Q2 2023. 703 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

Carnegie Investment Counsel held 7,527 shares of GE HealthCare worth $482K as of Q2 2026.
Carnegie Investment Counsel sold 18,735 GE HealthCare shares in Q2 2026, an estimated $1.23M.
GE HealthCare made up 0.01% of Carnegie Investment Counsel's portfolio in Q2 2026, its #398 holding.
Carnegie Investment Counsel first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
Carnegie Investment Counsel's GE HealthCare position peaked at $4.17M in Q2 2023.
703 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.